A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.

Ni H, Chan KB, Cheng Q, Chen K, Xie M, Wang H, Chan WE, Chen S

Open source

DOI
10.1016/j.jinf.2022.05.004
Published
2022 Aug
Container
The Journal of infection
Publisher
Not recorded
Open access
unknown

Credibility signals

supported Score 73/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jinf.2022.05.004,
  title = {A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.},
  author = {Ni H and Chan KB and Cheng Q and Chen K and Xie M and Wang H and Chan WE and Chen S},
  year = {2022},
  journal = {The Journal of infection},
  doi = {10.1016/j.jinf.2022.05.004},
  url = {https://doi.org/10.1016/j.jinf.2022.05.004}
}

RIS

TY  - JOUR
TI  - A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.
AU  - Ni H
AU  - Chan KB
AU  - Cheng Q
AU  - Chen K
AU  - Xie M
AU  - Wang H
AU  - Chan WE
AU  - Chen S
PY  - 2022
JO  - The Journal of infection
DO  - 10.1016/j.jinf.2022.05.004
UR  - https://doi.org/10.1016/j.jinf.2022.05.004
ER  - 

APA

H, N., KB, C., Q, C., K, C., M, X., H, W., WE, C., & S, C. (2022). A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.. The Journal of infection. https://doi.org/10.1016/j.jinf.2022.05.004

Source records